Autres langues Guiyang Xintian Pharmaceutical Co.,Ltd.

Actions

002873

CNE100002QB5

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 25/04/2024			Varia. 5j.	Varia. 1 janv.
11,38 ^CNY	+0,26 %		+0,26 %	-8,67 %

12/04	Guiyang Xintian Pharmaceutical Co. annonce sa proposition de distribution des bénéfices pour 2023	CI
11/04	Guiyang Xintian Pharmaceutical Co. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Guiyang Xintian Pharmaceutical Co.,Ltd. Announces Profit Distribution Proposal for 2023	12/04
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	11/04
Guiyang Xintian Pharmaceutical Co.,Ltd. signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd.	07/04
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.	02/04
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Equity Buyback.	05/02
Guiyang Xintian Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	04/02
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.	02/02
Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback announced on December 23, 2023 has closed with 4,017,200 shares, representing 1.73% for CNY 38.41 million.	02/02
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.	31/01
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.	03/01
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 15 million worth of its shares.	22/12
Guiyang Xintian Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	22/12
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Guiyang Xintian Pharmaceutical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 01 June 2023	24/05/23
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Guiyang Xintian Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year of 2022	21/04/23
Guiyang Xintian Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year of 2022	28/03/23
Guiyang Xintian Pharma Tapped to Produce Traditional Chinese Medicine for Hospital	27/12/22
Shanghai Huilun Biotechnology Co., Ltd. announced that it has received CNY 102 million in funding from Guiyang Xintian Pharmaceutical Co.,Ltd. and other investors	13/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Guiyang Xintian Pharmaceutical Co.,Ltd.

Actions

002873

CNE100002QB5

Autres langues

Filtres